Premium Information is available for this item - Upgrade for $1 a day
6505-01-048-2009
Usp Furosemide Tablets
6505010482009 010482009 LASIX
INC: 30946 Furosemide Tablets
![]()
November 2023
8

Marketplace 6505-01-048-2009
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-048-2009 5+ Documents (More...)
6505010482009,LASIX Usp Furosemide Tablets 6505010482009 ,LASIX Usp Furosemide 998986517,LASIX ,LASIX
,LASIX Usp Furosemide 6505010482009,LASIX Usp Furosemide Tablets 6505010482009 ,LASIX Usp Furosemide
,LASIX Usp Furosemide 6505010482009,LASIX Usp Furosemide Tablets 6505010482009,LASIX Usp ,LASIX Usp Furosemide
,LASIX Usp Furosemide 6505010482009,LASIX Usp Furosemide Tablets 6505010482009 ,LASIX Usp Furosemide
/us 6505-01-048-2009 Usp Furosemide Tablets 6505010482009,LASIX Tablets 6505010482009 ,LASIX Usp Furosemide
/fsc-6505/uk 6505-99-898-6517 Furosemide 6505998986517998986517,LASIX ,LASIX 6505010482009,LASIX Usp
/fsg-65/fsc-6505/us
/us 6505-01-048-2009 Usp Furosemide Tablets 6505010482009,LASIX ,LASIX Usp Furosemide Tablets 6505010482009
,LASIX Usp Furosemide 6505010482009,LASIX Usp Furosemide Tablets 6505010482009 ,LASIX Usp Furosemide
Furosemide 6505010482009,LASIX Usp Furosemide Tablets 6505010482009 ,LASIX Usp Furosemide 998986517,
LASIX ,LASIX Usp Furosemide Tablets 6505010482009 Usp Furosemide ,LASIX Usp Furosemide Tablets 6505010482009
Restrictions 6505-01-048-2009
6505-01-048-2009 is a Usp Furosemide Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-048-2009
- NASA (G83V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-048-2009
- Part Number
- Manufacturer
- Status
- LASIX
- Manufacturer
- 04500 - Hoechst-Roussel Pharmaceuticals Inc (Obsolete)
- Original Design
- Original Design
Datasheet 6505-01-048-2009
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 40.000 Milligrams Furosemide Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 90.000 Tablets
- Total Primary Container Quantity [CSCW]
- 1
- Features Provided [CBBL]
- Scored
- Special Features [FEAT]
- White In Color
Similar Supply Items to 6505-01-048-2009


















Freight Information 6505-01-048-2009
6505-01-048-2009 has freight characteristics.. 6505-01-048-2009 has a variance between NMFC and UFC when transported by rail and the description should be consulted.